Polaris Partners

Polaris Partners is a multibillion-dollar investment firm founded in 1996 and headquartered in Boston, Massachusetts, with an additional office in San Francisco. The firm specializes in investing in healthcare and biotechnology companies, focusing on various aspects of the sector. Its healthcare portfolio includes companies that develop innovative care delivery models, such as digital health solutions, consumer-centric services, patient-provider interactions, as well as data science and analytics. In the biotechnology realm, Polaris targets life sciences firms engaged in research and development of therapeutics, genomic technologies, and molecular platforms. With over 20 years of experience, Polaris Partners collaborates with repeat entrepreneurs and innovators, supporting ventures from their inception through to profitable growth.

David Barrett

General Partner

Marissa Bertorelli

Principal

Alexandra Cantley

Partner

Darren Carroll

Partner

Brian Chee

Managing Partner

Harold Friedman

CFO

Dan Lombard

Partner

Eileen McGuire

Partner

Pat Mulach

Associate

Gary Swart

Partner

Sabrina Chiasson

Vice President

Past deals in Personal Health

Sunbird Bio

Venture Round in 2024
Sunbird Bio is a diagnostics platform developer focused on advancing molecular diagnostics to deliver faster and more accurate results. Founded by Huilin Shao, the company specializes in detecting a wide array of diseases, including infectious diseases, neurodegenerative disorders, and cancer. By enabling early diagnosis, Sunbird Bio aims to enhance healthcare outcomes and support physicians in making informed decisions. The platform is designed to improve clarity and accessibility in diagnostic testing, thereby contributing to better patient care.

Livara

Series B in 2024
Livara Health specializes in non-operative, personalized treatment for musculoskeletal conditions, focusing primarily on back and neck pain. The company has developed an orthopedic care management platform that provides a comprehensive, data-driven approach to pain relief. This platform assesses patients' needs and customizes a six-week treatment program, which includes physical therapy coaching and addiction treatment options. Livara aims to help individuals alleviate their musculoskeletal issues through both online and onsite therapy, eliminating the need for surgical interventions.

FOLX

Series B in 2022
FOLX Health is a telehealth platform based in Boston, Massachusetts, that specializes in providing digital healthcare services for the LGBTQIA+ community. Launched in 2020, the platform creates a medical service marketplace specifically designed for queer and trans individuals. FOLX Health offers access to a network of clinicians who understand the unique needs of this community, focusing on services such as gender-affirming hormone therapy, sexual health, and family creation. The platform also provides virtual consultations, discreet delivery of at-home medication kits, and general medical services, aiming to eliminate the barriers and stigma often encountered in traditional healthcare settings. By prioritizing the health and well-being of LGBTQIA+ individuals, FOLX Health fosters a supportive environment for patients to manage their health needs.

Nomad Health

Venture Round in 2022
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.

Kallyope

Series D in 2022
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.

Nomad Health

Series D in 2021
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.

Wellthy

Series B in 2021
Wellthy, Inc. is a concierge service based in New York that assists individuals and families in managing care for chronically ill, aging, or disabled loved ones. Established in 2014, the company connects families with dedicated Care Coordinators who help navigate complex care situations, including aging-related issues such as dementia, diabetes, and cancer, as well as childcare and special needs. Wellthy's platform enables families to efficiently organize appointments, manage tasks, store essential documents, and maintain communication, alleviating the logistical burdens associated with caregiving. The service aims to provide relief to families by coordinating care and addressing related medical, legal, financial, and housing needs.

Thirty Madison

Series C in 2021
Thirty Madison, Inc. is a digital health company based in Astoria, New York, that operates web-based platforms tailored to patients with chronic conditions. Founded in 2016, the company offers a range of specialized healthcare brands, including Keeps for men’s hair loss, Cove for migraines, Picnic for allergies, Facet for skin conditions, and NURX for sexual health. Each brand is designed to provide personalized treatments and care, addressing the unique needs of its community. By focusing on specific ongoing conditions, Thirty Madison seeks to empower individuals through accessible and effective healthcare solutions, facilitating exceptional outcomes for patients over a lifetime of care.

Livara

Series A in 2021
Livara Health specializes in non-operative, personalized treatment for musculoskeletal conditions, focusing primarily on back and neck pain. The company has developed an orthopedic care management platform that provides a comprehensive, data-driven approach to pain relief. This platform assesses patients' needs and customizes a six-week treatment program, which includes physical therapy coaching and addiction treatment options. Livara aims to help individuals alleviate their musculoskeletal issues through both online and onsite therapy, eliminating the need for surgical interventions.

Thirty Madison

Series B in 2020
Thirty Madison, Inc. is a digital health company based in Astoria, New York, that operates web-based platforms tailored to patients with chronic conditions. Founded in 2016, the company offers a range of specialized healthcare brands, including Keeps for men’s hair loss, Cove for migraines, Picnic for allergies, Facet for skin conditions, and NURX for sexual health. Each brand is designed to provide personalized treatments and care, addressing the unique needs of its community. By focusing on specific ongoing conditions, Thirty Madison seeks to empower individuals through accessible and effective healthcare solutions, facilitating exceptional outcomes for patients over a lifetime of care.

FOLX

Venture Round in 2020
FOLX Health is a telehealth platform based in Boston, Massachusetts, that specializes in providing digital healthcare services for the LGBTQIA+ community. Launched in 2020, the platform creates a medical service marketplace specifically designed for queer and trans individuals. FOLX Health offers access to a network of clinicians who understand the unique needs of this community, focusing on services such as gender-affirming hormone therapy, sexual health, and family creation. The platform also provides virtual consultations, discreet delivery of at-home medication kits, and general medical services, aiming to eliminate the barriers and stigma often encountered in traditional healthcare settings. By prioritizing the health and well-being of LGBTQIA+ individuals, FOLX Health fosters a supportive environment for patients to manage their health needs.

Kallyope

Series C in 2020
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.

Nomad Health

Series C in 2019
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.

Wellthy

Series A in 2019
Wellthy, Inc. is a concierge service based in New York that assists individuals and families in managing care for chronically ill, aging, or disabled loved ones. Established in 2014, the company connects families with dedicated Care Coordinators who help navigate complex care situations, including aging-related issues such as dementia, diabetes, and cancer, as well as childcare and special needs. Wellthy's platform enables families to efficiently organize appointments, manage tasks, store essential documents, and maintain communication, alleviating the logistical burdens associated with caregiving. The service aims to provide relief to families by coordinating care and addressing related medical, legal, financial, and housing needs.

Kallyope

Series B in 2018
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.

Nomad Health

Series B in 2018
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.

Kallyope

Series B in 2018
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.

Kallyope

Series A in 2015
Kallyope Inc. is a biotechnology company based in New York City that focuses on the gut-brain axis to develop innovative therapeutics and consumer products aimed at enhancing human health. Founded in 2014, Kallyope employs a multidisciplinary approach, integrating technologies such as sequencing, computational biology, neural imaging, and human genetics to deepen the understanding of gut-brain biology. This comprehensive understanding enables the company to create effective and well-tolerated oral medications targeting various health issues, including diabetes, obesity, gut disorders, inflammatory diseases, migraines, and allergies. With a team of experienced scientists and a strong foundation in drug discovery, Kallyope aims to address significant unmet medical needs through its research and development efforts.

Arivale

Series B in 2015
Arivale Inc. is a wellness service provider that focuses on helping individuals optimize their health and prevent disease through a scientific approach. Founded in 2014 and headquartered in Seattle, Washington, the company analyzes various aspects of individual health, including genetics, blood markers, the gut microbiome, and lifestyle factors. By integrating this data, Arivale delivers tailored recommendations and personalized coaching to empower individuals in making informed decisions about their wellness. This comprehensive approach not only aids members in understanding their unique health profiles but also contributes to a growing dataset that supports medical research aimed at enhancing health outcomes.

First Opinion

Series A in 2014
First Opinion is like having a doctor in the family and from the convenience of your phone or computer. Doctors are available within minutes, 24-hours a day for all of your health-related questions. It's always free to ask and you can upgrade for treatment if necessary.

EXOS

Venture Round in 2012
EXOS, Inc. is a human performance company based in Phoenix, Arizona, with additional facilities in Los Angeles, San Diego, Frisco, Miami, and Charlotte. Founded in 1999, EXOS specializes in training, nutrition, physical therapy, and consulting services tailored for professional athletes, as well as individuals and organizations in various sectors. The company offers a wide range of services, including facility design and management, performance assessments, rehabilitation, and wellness programs. With a focus on evidence-based strategies, EXOS has developed integrated solutions for workplace wellness, serving corporate campuses, military bases, health clubs, academic institutions, and sports organizations. Formerly known as Athletes' Performance, Inc., the company rebranded to EXOS in January 2014 and has established itself as a leader in performance training and physical therapy worldwide.

Ella Health

Seed Round in 2011
Ella Health is a women's wellness provider headquartered in San Francisco, California, with multiple centers nationwide. The company offers healthcare services such as 3D mammography, which enhances cancer detection and minimizes false positives compared to traditional 2D imaging. In addition to mammography, Ella Health provides specialized physical therapy programs tailored to the unique needs of women at various life stages. The organization combines advanced technology with a compassionate approach, creating an inviting environment that resembles a spa rather than a typical medical facility. Through its innovative services, Ella Health empowers women to take control of their health and well-being.

Free & Clear

Venture Round in 2010
Free & Clear, Inc. specializes in phone-based tobacco treatment services aimed at employers, health plans, and government agencies. The company provides a comprehensive tobacco cessation program, known as the Quit For Life Program, which assists employees and members of private organizations in quitting smoking and using smokeless tobacco. Additionally, Free & Clear offers the Mind & Body Program, a behavioral change initiative designed to promote healthy weight management and address health risks associated with chronic diseases, such as tobacco use, poor nutrition, and physical inactivity. By delivering these clinically proven solutions, Free & Clear aims to support individuals in achieving healthier lifestyles.

HealthCentral

Post in 2008
HealthCentral Corporation is a digital health media company that focuses on providing information and resources for patients with chronic illnesses and healthcare professionals. Founded in 1999 and headquartered in Arlington, Virginia, HealthCentral operates over 30 condition-specific websites that cover a variety of health topics, including asthma, diabetes, and high blood pressure. These platforms offer users access to news articles, videos, community discussions, and reputable publications, enabling them to connect with both experts and fellow patients. Additionally, HealthCentral produces the nationally syndicated television show "Medical Breakthroughs with Dr. Dean Edell." The company faces competition from other health information platforms, such as WebMD and RevolutionHealth. HealthCentral was previously known as ChoiceMedia and has undergone various ownership changes since its founding.

EXOS

Series B in 2007
EXOS, Inc. is a human performance company based in Phoenix, Arizona, with additional facilities in Los Angeles, San Diego, Frisco, Miami, and Charlotte. Founded in 1999, EXOS specializes in training, nutrition, physical therapy, and consulting services tailored for professional athletes, as well as individuals and organizations in various sectors. The company offers a wide range of services, including facility design and management, performance assessments, rehabilitation, and wellness programs. With a focus on evidence-based strategies, EXOS has developed integrated solutions for workplace wellness, serving corporate campuses, military bases, health clubs, academic institutions, and sports organizations. Formerly known as Athletes' Performance, Inc., the company rebranded to EXOS in January 2014 and has established itself as a leader in performance training and physical therapy worldwide.

Ascend Health

Series B in 2007
Ascend Health Corporation is a behavioral healthcare provider that specializes in a comprehensive range of inpatient and day hospital services for individuals across various age groups, including children, adolescents, adults, and seniors. The organization operates freestanding psychiatric hospitals and offers a wide array of behavioral health programs, such as residential treatment centers, partial hospitalization, and intensive outpatient services. Ascend Health emphasizes personal choice and tailored care, ensuring that its services are effectively integrated with the local healthcare systems to deliver high-quality treatment for mental health and substance abuse issues.

EXOS

Series A in 2006
EXOS, Inc. is a human performance company based in Phoenix, Arizona, with additional facilities in Los Angeles, San Diego, Frisco, Miami, and Charlotte. Founded in 1999, EXOS specializes in training, nutrition, physical therapy, and consulting services tailored for professional athletes, as well as individuals and organizations in various sectors. The company offers a wide range of services, including facility design and management, performance assessments, rehabilitation, and wellness programs. With a focus on evidence-based strategies, EXOS has developed integrated solutions for workplace wellness, serving corporate campuses, military bases, health clubs, academic institutions, and sports organizations. Formerly known as Athletes' Performance, Inc., the company rebranded to EXOS in January 2014 and has established itself as a leader in performance training and physical therapy worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.